0001127602-12-023572.txt : 20120802
0001127602-12-023572.hdr.sgml : 20120802
20120802160706
ACCESSION NUMBER: 0001127602-12-023572
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120731
FILED AS OF DATE: 20120802
DATE AS OF CHANGE: 20120802
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PREVOZNIK MICHAEL E
CENTRAL INDEX KEY: 0001222679
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 121003506
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2012-07-31
0001022079
QUEST DIAGNOSTICS INC
DGX
0001222679
PREVOZNIK MICHAEL E
C/O QUEST DIAGNOSTICS INCORPORATED
3 GIRALDA FARMS
MADISON
NJ
07940
1
SVP & General Counsel
Common Stock
2012-07-31
4
M
0
28814
24.76
A
65435
D
Common Stock
2012-07-31
4
S
0
28814
58.592
D
36621
D
Common Stock
2012-07-31
4
M
0
11408
24.76
A
48029
D
Common Stock
2012-08-01
4
M
0
31778
24.76
A
79807
D
Common Stock
2012-08-01
4
M
0
54667
52.235
A
134474
D
Common Stock
2012-08-01
4
S
0
86445
58.6766
D
48111
D
Common Stock
4393
I
401k/SDCP
Stock Options (Right to Buy)
24.76
2012-07-31
4
M
0
28814
0
D
2013-02-13
Common Stock
28814
43186
D
Stock Options (Right to Buy)
24.76
2012-07-31
4
M
0
11408
0
D
2013-02-13
Common Stock
11408
31778
D
Stock Options (Right to Buy)
24.76
2012-08-01
4
M
0
31778
0
D
2013-02-13
Common Stock
31778
0
D
Stock Options (Right to Buy)
52.235
2012-08-01
4
M
0
54667
0
D
2013-02-15
Common Stock
54667
0
D
This transaction was executed in multiple trades at prices ranging from $58.40 to $58.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $58.25 to $59.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The amount includes approximately 30 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant.
The amount includes exempt purchases made under the Company's stock purchase plan
since the date of the last filing on Form 4.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k) and/or Supplemental Deferred Compensation Plan. The information was obtain from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
The options vested in three installments beginning with the first on February 13, 2004, the second on February 13, 2005 and the final on February 13, 2006.
The options vested in three installments beginning with the first on February 15, 2007, the second on February 15, 2008 and the final on February 15, 2009.
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Michael E. Prevoznik
2012-08-02